|
|
||||||||

* Department of Nutrition, School of Public Health and School of Medicine,
Department of Radiology, School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
1Correspondence: School of Public Health, CB #7461, McGavran-Greenberg Building, The University of North Carolina, Chapel Hill, NC 27599-7461, USA. E-mail: steven_zeisel{at}unc.edu
Phosphatidylethanolamine N-methyltransferase (PEMT) catalyzes phosphatidylcholine synthesis. PEMT knockout mice have fatty livers, and it is possible that, in humans, nonalcoholic fatty liver disease (NAFLD) might be associated with PEMT gene polymorphisms. DNA samples from 59 humans without fatty liver and from 28 humans with NAFLD were genotyped for a single nucleotide polymorphism in exon 8 of PEMT, which leads to a V175M substitution. V175M is a loss of function mutation, as determined by transiently transfecting McArdle-RH7777 cells with constructs of wild-type PEMT open reading frame or the V175M mutant. Met/Met at residue 175 (loss of function SNP) occurred in 67.9% of the NAFLD subjects and in only 40.7% of control subjects (P<0.03). For the first time we report that a polymorphism of the human PEMT gene (V175M) is associated with diminished activity and may confer susceptibility to NAFLD.Song, J., da Costa, K. A., Fischer, L. M., Kohlmeier, M., Kwock, L., Wang, S., Zeisel, S. H. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD).
Key Words: choline liver function single nucleotide polymorphism (SNP) nonalcoholic fatty liver disease pregnancy NTD transfection site-directed mutagenesis
This article has been cited by other articles:
![]() |
K.-A. da Costa, K. S. Rai, C. N. Craciunescu, K. Parikh, M. G. Mehedint, L. M. Sanders, A. McLean-Pottinger, and S. H. Zeisel Dietary Docosahexaenoic Acid Supplementation Modulates Hippocampal Development in the Pemt-/- Mouse J. Biol. Chem., January 8, 2010; 285(2): 1008 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Caudill, N. Dellschaft, C. Solis, S. Hinkis, A. A. Ivanov, S. Nash-Barboza, K. E. Randall, B. Jackson, G. N. Solomita, and F. Vermeylen Choline Intake, Plasma Riboflavin, and the Phosphatidylethanolamine N-Methyltransferase G5465A Genotype Predict Plasma Homocysteine in Folate-Deplete Mexican-American Men with the Methylenetetrahydrofolate Reductase 677TT Genotype J. Nutr., April 1, 2009; 139(4): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stefan, K. Kantartzis, and H.-U. Haring Causes and Metabolic Consequences of Fatty Liver Endocr. Rev., December 1, 2008; 29(7): 939 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, M. D. Gammon, S. H. Zeisel, Y. L. Lee, J. G. Wetmur, S. L. Teitelbaum, P. T. Bradshaw, A. I. Neugut, R. M. Santella, and J. Chen Choline metabolism and risk of breast cancer in a population-based study FASEB J, June 1, 2008; 22(6): 2045 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Vance, Z. Li, and R. L. Jacobs Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology J. Biol. Chem., November 16, 2007; 282(46): 33237 - 33241. [Full Text] [PDF] |
||||
![]() |
S. Romeo, J. C. Cohen, and H. H. Hobbs No association between polymorphism in PEMT (V175M) and hepatic triglyceride content in the Dallas Heart Study FASEB J, October 1, 2006; 20(12): 2180 - 2180. [Full Text] [PDF] |
||||
![]() |
S. H. Zeisel People with fatty liver are more likely to have the PEMT rs7946 SNP, yet populations with the mutant allele do not have fatty liver FASEB J, October 1, 2006; 20(12): 2181 - 2182. [Full Text] [PDF] |
||||
![]() |
K.-A. da Costa, O. G. Kozyreva, J. Song, J. A. Galanko, L. M. Fischer, and S. H. Zeisel Common genetic polymorphisms affect the human requirement for the nutrient choline FASEB J, July 1, 2006; 20(9): 1336 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Fukagawa Sparing of Methionine Requirements: Evaluation of Human Data Takes Sulfur Amino Acids Beyond Protein J. Nutr., June 1, 2006; 136(6): 1676S - 1681S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |